Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03229928 · ClinicalTrials.gov registry record

Clinical Testing of a Real-Time Behavior Measurement Tool: Measuring Outcomes for CHAnge

A clinical trial, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
10
Enrollment target

NCT03229928: Completed study, sponsored by University of North Carolina, Chapel Hill.

NCT03229928 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03229928 has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
10 participants
Enrollment target

Study Summary

The efficacy of clinical trials addressing behavioral issues in individuals with intellectual/developmental disabilities (IDD) has traditionally been hampered by lack of objective and sensitive measures. While there are many behavioral observation measures available, most of them either rely on recall of the event or are designed for use by trained professional observers, requiring a third party or extensive training for use. The Measuring Outcomes for CHange (MOCHA) phone based application was developed to address the need for feasible real-time tracking of behavior. For the current study, 2 parents of children with IDD, 2 special education teachers, and 2 behavior health professionals will be recruited to serve on a stakeholder advisory panel. These individuals will provide initial feedback on the use of the application. Primary participants will be the parents and teachers of 10 children or adolescents (age 5-17 years) who are seeking treatment and support for the child's challenging behaviors (aggression, self-injurious behaviors, severe irritability) from clinicians in the Behavior Medicine Clinic at the Carolina Institute for Developmental Disabilities. Participants in the study will use MOCHA to record the child's behavior each time it occurs over 6 weeks in order to test the feasibility of using MOCHA over time and in response to treatment. The first 2 weeks of data collection will occur prior to the participant's scheduled visit to the BMC. Following the clinic visit, where clinically determined treatment suggestions will be provided, participants will continue to collect data for 4 weeks to determine if long term data collection is feasible and if change can be detected in response to the treatment through MOCHA (and compared to pen and paper questionnaires). Two children will be chosen from this participant pool to wear a sensor device to determine feasibility of syncing wearable sensors with the MOCHA app for use in future research studies. Following the

Primary Outcome

The MOCHA exit interview is a study developed survey used to better understand client usability of MOCHA. Questions include items measured on a Likert scale measuring range of agree-ability (Strongly Disagree \[0\] to Strongly Agree \[5\]), frequency (Never \[0\] to Very Often \[4\]), or likelihood of use (Very Unlikely \[0\] to Very Likely \[5\]) to a question prompt. Additional open-ended questions are also included. The investigators will present the mean score obtained on these interview que

Interventions

  • DEVICE MOCHA

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2017-08-01
Est. Completion 2018-05-01

What the finished NCT03229928 record still lists

NCT03229928 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which MOCHA is the first listed.

NCT03229928 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03229928 about?

NCT03229928 is a clinical study titled "Clinical Testing of a Real-Time Behavior Measurement Tool: Measuring Outcomes for CHAnge". The efficacy of clinical trials addressing behavioral issues in individuals with intellectual/developmental disabilities (IDD) has traditionally been hampered by lack of objective and sensitive measures. While there are many behavioral observation measures available, most of them either rely on reca...

What is the current status of trial NCT03229928?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2017-08-01. Estimated completion is 2018-05-01.

What interventions are being tested in trial NCT03229928?

The interventions under investigation include: MOCHA (DEVICE).

Who is sponsoring clinical trial NCT03229928?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03229928, the US trial registry maintained by the National Library of Medicine. NCT03229928 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.